BRIEF-Perrigo announces FDA final approval for its AB rated generic version of Exalgo® 32mg extended release tablets

* Perrigo announces FDA final approval for its AB rated generic version of Exalgo® 32mg extended release tablets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.